We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Codexis Inc
12 own
9 watching
Current Price
$6.16
$-0.35
(-5.38%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
404.18M
52-Week High
22.22
52-Week Low
4.21
Average Volume
0.44M
Dividend Yield
--
P/E Ratio
--
Market Capitalization404.18M52-Week High22.2252-Week Low4.21Average Volume0.44MDividend Yield--P/E Ratio--What does the Codexis Inc do?
Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also improves the pharmaceuticals companies manufacturing productivity and efficiency, as well as helps in outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. Further, the company develops biocatalysts for use in the fine chemicals market, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Read More
How much money does Codexis Inc make?
News & Events about Codexis Inc.
Simply Wall St
4 months ago
It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...
Ticker Report
5 months ago
Skandinaviska Enskilda Banken AB publ cut its stake in Codexis, Inc. (NASDAQ:CDXS Get Rating) by 23.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,375 shares of the biotechnology ...
Globe Newswire
7 months ago
Collaboration with Merck published in Science magazine REDWOOD CITY, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announces the publication with Merck, known as MSD outside the United ...
Ticker Report
8 months ago
Qube Research Technologies Ltd reduced its position in Codexis, Inc. (NASDAQ:CDXS Get Rating) by 32.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,827 shares of the biotechnology companys stock after selling ...
Frequently Asked Questions
Frequently Asked Questions
What is Codexis Inc share price today?
Can Indians buy Codexis Inc shares?
How can I buy Codexis Inc shares from India?
Can Fractional shares of Codexis Inc be purchased?
What are the documents required to start investing in Codexis Inc stocks?
What is today’s traded volume of Codexis Inc?
What is today’s market capitalisation of Codexis Inc?
What is the 52-Week High and Low Range of Codexis Inc?
What percentage is Codexis Inc down from its 52-Week High?
What percentage is Codexis Inc up from its 52-Week Low?
Current Price
$6.16
$-0.35
(-5.38%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.